Johns Hopkins neurologist Kemar Green recaps a presentation from the 2024 meeting of the American Academy of Neurology, during which he discussed published preliminary data about the use of artificial intelligence and data from tracked eye movements to differentiate myasthenia gravis from other diseases that affect the eye.